COMPANY

STADA

STADA is a pharmaceutical group selling generics, specialty medicines and consumer healthcare.

Analyst Perspective

STADA Arzneimittel AG is a Germany-headquartered pharmaceutical and consumer healthcare company. It develops, manufactures and sells consumer healthcare products, generic medicines and specialty pharmaceuticals through a global operating footprint. Following CapVest Partners LLP's majority acquisition on 31 March 2026, STADA remains an active standalone operating group under private ownership. The company generates revenue primarily from the sale of pharmaceutical and healthcare products through healthcare distribution and retail channels. Its paying customers are pharmacies, wholesalers, hospitals, healthcare providers, retailers and distribution partners, with end-consumer demand supporting parts of the consumer healthcare portfolio. STADA's scale is evidenced by 2025 group sales of €4,296 million and 11,670 employees worldwide.

Analyst Signal Briefing

Updated: 30 Jul 2026

No strategic news signals detected in the last 90 days.

Explorer Tier

Start exploring for free

Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.

Free
  • View public Company Profiles
  • Save/watch companies
  • Build your first Watchlist
  • Access additional market signals

Category Differentiation

STADA is a pharmaceutical and consumer healthcare manufacturer, not an adtech, martech or software platform. It sells medicines and healthcare products rather than media, data or SaaS tools.

STADA: About

STADA operates a scaled pharmaceutical manufacturing and brand commercialisation model. It creates value by developing, manufacturing and distributing medicine and healthcare portfolios across generics, specialty pharmaceuticals and consumer health products, then monetises those products through B2B sales into healthcare and retail channels at volume.

How STADA Works & Monetises

Business model analysis and core revenue streams

STADA monetises through product sales of generics, specialty pharmaceuticals and consumer healthcare goods. Revenue is generated primarily via wholesale and institutional distribution, pharmacy and retail sell-in, and broader branded healthcare product sales rather than software subscriptions or advertising.

Revenue Channels

Generic pharmaceuticals salesOne-time Sale
Consumer healthcare product salesRetail Margin
Specialty pharmaceuticals salesOne-time Sale

Side-by-Side Comparisons

Compare STADA directly with top competitors

STADA: Key Competitors & Alternatives

View full competitor landscape

Recent Signals (STADA)

HorizontAug 3, 2026

Huth+Wenzel wins Stada's Elotrans Reload account

Frankfurt-based agency Huth+Wenzel has won the creative account for Stada's Elotrans Reload. The first joint campaign is running immediately through mid-October across social media, Connected TV, linear TV (channels like RTL Zwei), digital out-of-home and ambient placements. The account move ends the prior cooperation with Schmittgall Health, which had handled the brand since the product launch in 2023. The campaign centers on a humorous fictional character named "Stefan" and the agency says it used artificial intelligence as a creative tool to develop Out-of-Home motifs. Claudia Rodrigues (Brand Manager at Stada) and Andreas Liehr (Huth+Wenzel managing director) are quoted on the campaign approach.

Read original source
OMRMay 7, 2023

Meet the 50 Influencers Shaping Digital in 2023

OMR published its annual OMR50 ranking for 2023 — a subjective, editorial list of 50 influential people from the digital, startup and creator economy presented at OMR Festival 2023 in partnership with Ströer and HORIZONT. The list spans founders (AI, fintech, consumer goods), creators and agency/executive figures, and highlights recent funding rounds, exits and trends such as generative AI, creator-led product launches and D2C scaling. Notable entries and signals in the piece include Celonis (Series D / $1bn round and $13bn valuation), Aleph Alpha and You.com on the AI frontier (parameter claims and fundraising/rumours), the German federal Deep Tech & Climate Fund (DTCF) with up to €1bn under Elisabeth Schrey, and several creator-to-brand success stories and exits. OMR frames the list as infotainment and a directional snapshot of who matters in the German-speaking digital ecosystem in 2023.

Read original source

STADA: Frequently Asked Questions

What is STADA?

STADA is a Germany-headquartered pharmaceutical group that develops, manufactures and sells consumer healthcare products, generics and specialty pharmaceuticals.

Who uses STADA?

STADA's products are bought by pharmacies, wholesalers, hospitals, healthcare providers, distributors and retail partners, with many products ultimately used by patients and consumers.

How does STADA make money?

STADA makes money by selling pharmaceutical and consumer healthcare products through healthcare, wholesale and retail distribution channels.

Company Facts

Headquarters
Stadastraße 2-18, 61118 Bad Vilbel
Core Segment
Advertiser / Brand
Company Size
>5,000
Official Link
stada.com